About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD23.26
- USD23.57
- USD22.53
- USD34.76
- -10.90%
- 14M
- 572.45k
- 570.34k
- 1.2B
- 16.75
- -20.90%
Stock News
1 hour ago
: Virgin Orbit stock plunges after report says company will cease operations
MarketWatch
1 hour ago
: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged
MarketWatch
1 hour ago
NY grand jury indicts Trump in hush money payment case
CNBC
2 hours ago
Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
